AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026. Takeda Pharmaceutical ...

Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

HRV Pharma’s innovative “virtual manufacturing” model connects FDA-approved facilities to prevent prescription shortages and keep medicine cabinets stocked American pharmacies faced a crisis in 2024: ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

A Co-CEO of a leading neurotherapeutics developer reported significant insider selling amid a year of standout stock ...

The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs ...

The drugmaker is doing nearly everything else right.

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

The buyer is Siegfried Holding AG, a global contract development and manufacturing organization for the pharmaceutical industry.

A pharmaceutical maker argues a lawsuit filed against it over stomach acid reducers belongs in federal court, not a Louisiana state court.